Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Tauschmann

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Diabetes Science and Technology|March 18, 2024
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized TrialD Steven Fox, Julia Ware, Charlotte K Boughton, et al.
The Lancet. Digital Health|March 11, 2022
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Diabetes Care|June 22, 2019
Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin DeliveryKlemen Dovc, Charlotte Boughton, Martin Tauschmann, et al.
The New England Journal of Medicine|January 19, 2022
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 DiabetesJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
Diabetes Technology & Therapeutics|May 25, 2023
Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin DeliveryHeba Alwan, Julia Ware, Charlotte K Boughton, et al.
Hormone Research in Paediatrics|December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia|December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.
Diabetes Care|January 30, 2019
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized TrialMartin Tauschmann, Janet M Allen, Katrin Nagl, et al.
Pediatric Diabetes|May 30, 2019
Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetesGianluca Musolino, Klemen Dovc, Charlotte K Boughton, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Diabetes Science and Technology|March 18, 2024
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized TrialD Steven Fox, Julia Ware, Charlotte K Boughton, et al.
The Lancet. Digital Health|March 11, 2022
Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Diabetes Care|June 22, 2019
Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin DeliveryKlemen Dovc, Charlotte Boughton, Martin Tauschmann, et al.
The New England Journal of Medicine|January 19, 2022
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 DiabetesJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
Diabetes Technology & Therapeutics|May 25, 2023
Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin DeliveryHeba Alwan, Julia Ware, Charlotte K Boughton, et al.
Hormone Research in Paediatrics|December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia|December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.
Diabetes Care|January 30, 2019
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized TrialMartin Tauschmann, Janet M Allen, Katrin Nagl, et al.
Pediatric Diabetes|May 30, 2019
Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetesGianluca Musolino, Klemen Dovc, Charlotte K Boughton, et al.
Pageof 7